Markets

Unusual Volume Spotted in Argos Therapeutics, Inc. (NASDAQ:ARGS) Stock

Unusual Volume Spotted in Argos Therapeutics, Inc. (NASDAQ:ARGS) Stock

A total of 6,022,508 shares exchanged hands during the intra-day trade contrast with its average trading volume of 4.69M shares, while its relative volume stands at 1.29. The relative volume of the stock is 3.71, while its market cap is $12.79 Million. RSI oscillates between zero and 100. Usually the RSI is considered overbought when above 70 and oversold when less than 30.

Argos Therapeutics, Inc., an immuno-oncology company, focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. (ARGS) is at 39.35. Technology, health care and financial stocks accounted for much of the market's gains. This is the price at which the trader or investor wants to exit his existing position so he can realize the most reward. Out of 2 Wall Street analysts rating Argos Therapeutics, 0 give it "Buy", 0 "Sell" rating, while 2 recommend "Hold". Since analyst price targets calculations are subjective, there often can be wide range of targets from various analysts.

Argos Therapeutics (NASDAQ:ARGS) last released its quarterly earnings results on Thursday, November 9th. The company posted an earnings surprise of 50%.

The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? A high P/E suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E. Average estimation for the current quarter has been provided by 1 analysts. Looking at the stock's movement on the chart, Argos Therapeutics, Inc. recorded a 52-week high of $5.50. Stifel reported 0% of its portfolio in Argos Therapeutics, Inc.

Revenue is the amount of money that a company actually receives during a specific period, including discounts and deductions for returned merchandise. (NASDAQ:ARGS) that has shown a discernible change in trend levels over the path of recent market activity. Argos Therapeutics has a 1-year low of $0.12 and a 1-year high of $5.50.




INPX now trades at a P/S of 0.15 while ARGS trades at a P/S of 31.98. (ARGS) stock is moving with downswing trend. There are advantages to using a moving average in your trading, as well options on what type of moving average to use. About 874,221 shares traded. The Firm has ATR of 0.02 that is explaining range of a day's trading is high-low; ATR expands it to yesterday's closing price if it was outside of latest range. This volatility measure use for multipurpose in judging the underlying price momentum as well as the rate of change in ARGS's price.

Argos Therapeutics Inc (NASDAQ:ARGS) CEO Jeffrey D. Abbey sold 114,702 shares of the company's stock in a transaction dated Wednesday, January 3rd. It has a 36-month beta of 1.41, so you might be in for a bumpy ride. This gauge is crucial in determining whether investors are moved toward the direction of buying more of the stock, or else doing the contradictory side and selling more of the stock. Wasatch Advisors Inc. owned 1.21% of Argos Therapeutics at the end of the most recent reporting period. (ARGS) has an Analysts' Mean Recommendation of 3, according to data compiled by Finviz. Mean recommendation is rated on a 1 to 5 scale. The stock decreased 1.34% or $0.35 during the last trading session, reaching $25.77. This analysis is based on historical data about the stock's performance given the overall trends of the market and particular indicators within the market.

Argos Therapeutics, Inc. (ARGS)'s ROE is -3419.65%, while industry's is 16.53%.

Short interest or otherwise called the percentage of a stock's tradable shares now being shorted is another data that investors use to get a handle on sentiment.


  • Align Technology, Inc. (ALGN) Stake Lessened by Nisa Investment Advisors LLC

    Motley Fool Wealth Management LLC's holdings in Align Technology were worth $13,629,000 as of its most recent filing with the SEC. The stock increased 2.18% or $5.52 during the last trading session, reaching $258.43. 934,512 shares of the company traded hands.
    Drone flies to rescue two NSW swimmers

    Drone flies to rescue two NSW swimmers

    The rescue assistance came after the New South Wales government announced it would invest $430,000 in drone technology last month.
    Predicted Gunners XI for Premier League match v Crystal Palace

    Predicted Gunners XI for Premier League match v Crystal Palace

    Lacazette's goal also had the honour of being the 500th Premier League goal that has been scored for Arsenal by French players. The club-record signing was without a goal since the 3-1 defeat against Manchester United at the start of December.
  • Michael Carrick to 'become first-team coach at club'

    Michael Carrick to 'become first-team coach at club'

    Carrick hasn't featured for Jose Mourinho's side since September after undergoing heart surgery. Carrick is back in full training and is expected to make his return to the first team soon.
    Details of Dolores O'Riordan's funeral announced

    Details of Dolores O'Riordan's funeral announced

    At the opening, the coroner's officer said O'Riordan was staying at a hotel in London when she was found unresponsive in her room. Koretsky posted a photo on Instagram with O'Riordan on January 1 with the caption, "NYE: take away, TV, pajamas".

    Tufton Capital Management Acquires 3505 Shares of QUALCOMM, Inc. (QCOM)

    The insider STERLING MICHELLE M sold $245,919. 6 analysts say it's a Hold while 0 analysts provided their expert opinion as Sell. The company was maintained on Friday, February 12 by Mizuho. (NYSE:MGA) has "Hold" rating given on Thursday, August 6 by Zacks.
  • Patriots QB Tom Brady will start AFC Championship game against Jaguars

    Because this would go down as one of the biggest in National Football League history, even if Tom Brady's hand isn't 100 per cent. But the issue certainly bears watching for the 40-year-old All-Pro, especially given the challenge that the Jaguars present.
    Kings G DeSmith beats Penguins in starting debut

    Kings G DeSmith beats Penguins in starting debut

    Kempe tied it up at 1-1 at the 5:50 mark of the second period, but the Penguins put it away in the third with a pair of goals. With the amount of three point games there are during the stretch drive, it can be impossible to gain ground.
    Rajkummar Rao gets 2 Best Actor nominations in Filmfare's Critics' Awards

    Rajkummar Rao gets 2 Best Actor nominations in Filmfare's Critics' Awards

    With the crème la crème of the business under one roof, the show's host is none other than Bollywood's Badshaah Shah Rukh Khan . Best original story went to Amit Masurkar for Newton and best dialogue to Hitesh Kewalya for Shubh Mangal Saavdhan .
  • Desperate Aussies bring in changes at SCG

    Desperate Aussies bring in changes at SCG

    England were battling to build a defendable total as Australia's bowlers put the squeeze on in the third one-day worldwide in Sydney.
    Curious no-call in final seconds dooms Kentucky in loss vs. Florida

    Curious no-call in final seconds dooms Kentucky in loss vs. Florida

    Kentucky used its size advantage to outrebound Florida 49-38, and the Wildcats also outscored the Gators in the paint 38-26. Earlier this week, Kentucky lost to unranked SC 76-68, and Saturday night unranked Florida beat United Kingdom 66-64.
    At Baltimore's Women's March, participants look to the future

    At Baltimore's Women's March, participants look to the future

    During the 2016 election, a leaked " Access Hollywood " tape revealed Trump bragging in vulgar terms about groping women. The marches also focused on women's rights and protesting Trump's policies and rhetoric on women and minorities.